Stay informed with the latest headlines
Concerned about your child’s career in an AI world? Governor Gavin Newsom is rolling out free, Big Tech–backed AI curricula across high schools, community colleges and the California State University system, in partnership with Alphabet Inc. (NASDAQ:GOOGL), Adobe Inc. (NASDAQ:ADBE), International Business Machines Corp. (NYSE:IBM) and Microsoft Corp. (NASDAQ:MSFT).On Aug. 7 in San Francisco, Newsom […]
Read More
TORRANCE, Calif., July 31, 2025 (GLOBE NEWSWIRE) — Navitas Semiconductor (NASDAQ:NVTS), the industry leader in next-generation GaNFastTM gallium nitride (GaN) and GeneSiCTM silicon carbide (SiC) power semiconductors, today announced that Xiaomi’s next-generation 90W GaN charger will be powered by Navitas’ GaNSense Control ICs.As the world’s smallest 90 W charger, this ultra-compact, high-power-density form-factor measures just […]
Read More
BofA Securities analyst Peter T. Galbo initiated coverage on Primo Brands Corporation (NYSE:PRMB), with a price forecast of $42.Galbo notes that Primo Brands stock is expected to appreciate over the next 12 months as the company realizes cost synergies, targeting $300 million in EBITDA by 2026.If valuation multiples stay steady, this should support growth in […]
Read More
Guardant Health, Inc. (NASDAQ:GH) on Thursday announced a strategic collaboration with Pfizer, Inc. (NYSE:PFE) to support the development and commercialization of Pfizer’s oncology portfolio using the Guardant Infinity smart liquid biopsy platform.Under the multi-year collaboration agreement, Guardant and Pfizer aim to:Utilize Guardant’s portfolio of liquid biopsy tests in Pfizer’s global clinical studies.Evaluate the clinical utility […]
Read More
JPMorgan on Thursday shared updated thoughts on Ultragenyx Pharmaceutical Inc’s (NASDAQ:RARE) setrusumab program in osteogenesis imperfecta (OI).In a fourth-quarter 2024 press release, the company said patients continue dosing in the Phase 3 Orbit and Cosmic trials, which evaluate setrusumab in pediatric and young adult patients with OI.The randomized, placebo-controlled Phase 3 portion of the Orbit […]
Read More
TRIESEN, Liechtenstein, Feb. 24, 2025 /PRNewswire/ — Following the success of last year’s EdHeroes Global Forum on Cultural Heritage in Education, the global education network EdHeroes introduces a fresh new initiative to integrate cultural heritage into education worldwide called EdHeroes Cultural Heritage in Education Committee. This initiative will foster cross-border collaboration to ensure that cultural […]
Read More
Murder Mystery Game Market is Segmented by Type (Reasoning Type, Comedy Type, Dress Up Type), by Application (Online Game, Offline Game).BANGALORE, India, Feb. 13, 2025 /PRNewswire/ — The Murder Mystery Game Market was valued at USD 1162 Million in the year 2024 and is projected to reach a revised size of USD 51927900 Million by […]
Read More
On Friday, Novo Nordisk A/S (NYSE:NVO) released headline results from the REDEFINE 1 Phase 3 trial in the global REDEFINE program.When evaluating the effects of treatment if all people adhered to treatment, people treated with CagriSema achieved a weight loss of 22.7% after 68 weeks compared to a reduction of 11.8% with cagrilintide 2.4 mg, […]
Read More
Insomniac Games has announced that Marvel’s Spider-Man 2 will not receive any additional story content, effectively ending fan hopes for downloadable content (DLC). This news arrived alongside Sony Group Corp’s (NYSE:SONY) confirmation that a PC version of the game will be released in January 2025, making it one of the fastest transitions from a PS5 […]
Read More
Last week, Rivian Automotive (NASDAQ: RIVN) drastically slashed its 2024 outpout goal over yet another supply chain disrution. Bloomberg reported that a communication blunder left the EV maker without critical supplies. With this big blow to its supply chain, growth is in for a major setback this year as this supply chain fumble will cost […]
Read More